E-4010, a selective phosphodiesterase 5 inhibitor, attenuates hypoxic pulmonary hypertension in rats

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.

1989 • 2,183 citations

Nihon-kokyuki-gakkai-zasshi

2011 • 1,284 citations

Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

1991 • 1,134 citations

Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension

1991 • 1,062 citations

Regulation of the Erythropoietin Gene: Evidence That the Oxygen Sensor Is a Heme Protein

1988 • 1,042 citations

Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary Hypertension

1998 • 674 citations

Advances in second messenger and phosphoprotein research

1992 • 481 citations

Atrial natriuretic factor receptors and signal transduction mechanisms.

1993 • 362 citations

Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease.

1993 • 339 citations

Nitric oxide and the lung.

1994 • 270 citations

New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.

1976 • 251 citations

Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase.

1990 • 232 citations

Cyclic Nucleotide Phosphodiesterases and Vascular Smooth Muscle

1996 • 205 citations

Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension

1995 • 183 citations

Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats.

1996 • 170 citations

BQ123, an ETA-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats

1994 • 122 citations

Vascular remodeling: mechanisms and implications.

1993 • 102 citations

Effect of Tacrolimus Hydrate (FK506) Ointment on Spontaneous Dermatitis in NC/Nga Mice

1998 • 92 citations

Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zaprinast in awake lambs

1995 • 89 citations

M&B 22948, a cGMP phosphodiesterase inhibitor, is a pulmonary vasodilator in lambs

1993 • 88 citations

Inhaled nitric oxide: clinical applications, indications, and toxicology

1997 • 85 citations

A selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery.

1995 • 68 citations

NIP-121 is more effective than nifedipine in acutely reversing chronic pulmonary hypertension

1993 • 57 citations

Dual cell cycle-specific mechanisms mediate the antimitogenic effects of nitric oxide in vascular smooth muscle cells

1997 • 57 citations

Pulmonary Hypertensive Diseases

1984 • 49 citations

Introduction

1993 • 46 citations

Calcium-calmodulin-stimulated and cyclic-GMP-specific phosphodiesterases. Tissue distribution, drug sensitivity, and regulation of cyclic GMP levels.

1992 • 26 citations

A selective type V phosphodiesterase inhibitor, E4021, protects the development of right ventricular overload and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension

1996 • 22 citations

Nonpeptide endothelin receptor antagonists. X. Inhibition of endothelin-1- and hypoxia-induced pulmonary pressor responses in the guinea pig by the endothelin receptor antagonist, SB 217242.

1997 • 21 citations

Signal transduction in erythropoiesis

1991 • 20 citations

E4021, a Selective Phosphodiesterase 5 Inhibitor, Potentiates the Vasodilator Effect of Inhaled Nitric Oxide in Isolated Perfused Rat Lungs

1999 • 8 citations

[E 4021, a cGMP phosphodiesterase inhibitor, is a selective pulmonary vasodilator in chronically hypoxic pulmonary hypertensive rats].

1998 • 6 citations

Cited By (0)

Loading...